STOCK TITAN

Bankwell Financial Group Inc Form 4 Filings

BWFG NASDAQ

Every Form 4 that Bankwell Financial Group Inc (BWFG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow BWFG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BWFG filings page.

Rhea-AI Summary

Bankwell Financial Group, Inc. (BWFG) director and ten percent owner Lawrence B. Seidman reported multiple open-market purchases of common stock on September 8, 2026, totaling 5,266 shares at prices in the mid-$60s per share, all reported as indirect ownership.

The purchases were made through several affiliated entities and a Deferred Compensation Plan, with post-transaction indirect holdings including 5,110 shares in the Deferred Compensation Plan, 225,640 shares by Seidman and Associates, L.L.C., and additional six-figure positions in other Seidman-related partnerships and LLCs. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

Bankwell Financial Group, Inc. (BWFG) director Eric J. Dale reported purchasing 530 shares of common stock on September 8, 2026 at $67.11 per share through a Deferred Compensation Plan, bringing his indirectly held stake in that plan to 43,026 shares of common stock.

Separate holding entries describe multiple restricted stock awards previously granted under the 2022 Bankwell Financial Group, Inc. Stock Plan, with portions vesting annually through February 2029.

Rhea-AI Summary

Bankwell Financial Group, Inc. (BWFG) director Jeffrey R. Dunne reported purchasing 261 shares of common stock on September 8, 2026 at $67.11 per share through a Deferred Compensation Plan, bringing his indirect holdings in that plan to 6,381 shares of common stock. The filing also lists several outstanding restricted stock awards granted under the 2022 stock plan with scheduled vesting dates through February 2029. No transactions were reported under a Rule 10b5-1 trading plan.

Rhea-AI Summary

Bankwell Financial Group, Inc. (BWFG) director Blake S. Drexler reported an open‑market purchase of 116 shares of common stock on September 8, 2026 at $67.11 per share through a Deferred Compensation Plan, bringing that indirect plan holding to 37,049 shares. Additional reported positions include 1,128 shares held indirectly via an IRA‑401(k) and 58,224 shares held by family members over which he exercises effective control. Multiple restricted stock grants from 2022–2026 under company stock plans are disclosed with detailed vesting schedules, some of which have partially vested as of the filing date. No Rule 10b5‑1 trading plan is reported.

Rhea-AI Summary

Bankwell Financial Group, Inc. (BWFG) director Carl M. Porto reported an open-market-style purchase of 327 shares of common stock on September 8, 2026 at $67.11 per share, acquired indirectly through a Deferred Compensation Plan, bringing that plan’s reported holdings to 22,397 shares. He also reports indirect ownership of 4,303 shares through a Law Firm Pension Plan and multiple grants of restricted stock that vest in annual installments under the company’s 2012 and 2022 Stock Plans.

No Rule 10b5-1 trading plan is indicated for this transaction.

Rhea-AI Summary

Bankwell Financial Group, Inc. (BWFG) director Lawrence B. Seidman reported multiple open‑market purchases of common stock on August 25, 2026, totaling 2,540 shares at prices between $65.89 and $66.01, all held indirectly through affiliated entities including Seidman and Associates, L.L.C., several investment partnerships and L.L.C.s, and Chewy Gooey Cookies, L.P. Indirect holdings reported after these trades include, for example, 223,684 shares via Seidman and Associates, L.L.C. and 178,352 shares via Seidman Investment Partnership II, L.P., plus 4,844 shares held through a Deferred Compensation Plan. Footnotes also describe previously granted restricted stock awards (1,455; 1,800; and two grants of 1,600 shares) that vest in annual installments through 2029. The Rule 10b5‑1 checkbox is not marked as being used for these transactions.

Rhea-AI Summary

Bankwell Financial Group, Inc. director Lawrence B. Seidman reported multiple open-market purchases of Common Stock on August 7, 2026, totaling 10,000 shares at prices around the mid-$60s per share. All purchases were made indirectly through affiliated entities, including Seidman and Associates, L.L.C., several investment partnerships, and other LLCs and LPs. Following these transactions, reported indirect holdings include 222,690 shares at Seidman and Associates, L.L.C. and 4,844 shares in a Deferred Compensation Plan. Footnotes also describe previously granted restricted stock awards under Bankwell’s stock plans with staggered vesting dates through 2029.

Rhea-AI Summary

Bankwell Financial Group, Inc. Chief Innovation Officer Ryan Jason Hildebrand reported a sale of 2,246 shares of common stock on July 31, 2026 at a reported price of $66.74 per share, with individual sale prices ranging from $65.99 to $67.05.

He has also been granted 15,000 performance restricted shares that cliff vest on February 7, 2028 if performance goals are achieved, and 3,116 restricted shares split equally between time-based vesting from February 7, 2027 and performance-based vesting on February 7, 2029, all under the 2022 stock plan.

Rhea-AI Summary

Bankwell Financial Group, Inc. Chief Innovation Officer Ryan Jason Hildebrand reported a share sale tied to tax withholding on recently vested stock. On July 1, 2026, 1,088 shares of common stock were sold at $58.48 per share through the company’s cashless stock exercise program to cover tax liabilities on the vesting of 3,334 shares.

After this transaction, he directly holds 2,246 common shares. In addition, he holds 15,000 performance restricted shares granted under the 2022 Stock Plan, which have a three-year cliff vesting on February 7, 2028 if performance goals are met. He also holds 3,116 restricted and performance restricted shares from the same plan, with half vesting in three equal annual installments starting February 7, 2027 and half subject to three-year cliff vesting on February 7, 2029 based on performance.

Rhea-AI Summary

Bankwell Financial Group director Lawrence B. Seidman reported an indirect open-market purchase of Bankwell common stock. On June 5, 2026, a Deferred Compensation Plan associated with him bought 323 shares at $53.70 per share, increasing that plan’s holdings to 4,844 shares.

The filing also lists Seidman’s other direct and indirect holdings through several investment entities, along with multiple restricted stock grants that are scheduled to vest in tranches between 2026 and 2029 under Bankwell’s stock plans.

Rhea-AI Summary

Bankwell Financial Group director Eric J. Dale reported an open-market purchase of common stock. On June 5, 2026, he bought 588 shares of Bankwell Financial Group, Inc. common stock at $53.70 per share through a Deferred Compensation Plan, increasing his indirect holdings there to 42,496 shares.

Separate entries show direct holdings of Bankwell common stock and multiple restricted stock grants under the 2022 Bankwell Financial Group, Inc. Stock Plan with scheduled vesting dates through 2029. As of the filing date, the footnotes state that 1,200, 1,066, and 600 shares from different grants have vested.

Rhea-AI Summary

Bankwell Financial Group, Inc. director Blake S. Drexler reported a small open-market purchase of 79 shares of common stock at $53.70 per share on June 5, 2026, through a Deferred Compensation Plan, bringing that plan’s holdings to 36,933 shares.

The filing also updates his broader ownership picture, including 160,861 shares held directly, 58,224 shares held by family members over which he exercises effective control, and 1,128 shares held through an IRA/401(k), along with several tranches of restricted stock granted under company stock plans with scheduled vesting over future years.

Rhea-AI Summary

Bankwell Financial Group director Jeffrey R. Dunne made an open-market purchase of 315 shares of common stock at $53.70 per share on June 5, 2026 through a Deferred Compensation Plan, bringing that indirect holding to 6,120 shares. The filing also outlines multiple restricted stock awards under the 2022 Stock Plan with vesting tranches scheduled from February 2026 through February 2029.

Rhea-AI Summary

Bankwell Financial Group, Inc. director Carl M. Porto reported an open-market purchase of company stock. On June 5, 2026, he bought 370 shares of Bankwell Financial Group common stock at $53.70 per share through a Deferred Compensation Plan, bringing that plan’s holdings to 22,070 shares.

He also reports various direct and indirect restricted stock positions. Footnotes describe grants of 1,600 shares on December 31, 2022, 1,600 shares on December 29, 2023, 1,800 shares on February 7, 2025, and 1,455 shares on February 9, 2026 under company stock plans, with portions of these awards already vested as of the filing date.

Rhea-AI Summary

Bankwell Financial Group director Todd Lampert reported an open-market sale of 3,500 shares of common stock on June 5, 2026, at an average price of $53.59 per share. After this sale, he directly holds 12,366 common shares and also reports indirect holdings through an IRA and a spouse's IRA.

The filing also details multiple grants of restricted stock under Bankwell’s 2012 and 2022 Stock Plans, with portions scheduled to vest annually between 2026 and 2029. These awards represent ongoing equity-based compensation that increases his exposure to Bankwell’s future performance.

Rhea-AI Summary

Bankwell Financial Group director Lawrence B. Seidman and related entities increased their holdings through open‑market purchases of common stock. On June 1, 2026, they bought a combined 3,381 shares of BWFG at prices around $51.85–$52.04 per share.

Seidman personally acquired 81 shares at $51.95, bringing one direct holding line to 17,463 shares. Indirectly, entities such as Seidman and Associates, L.L.C., Seidman Investment Partnership II, L.P. and others now report six‑figure share positions. Additional footnotes describe multi‑year vesting schedules for several restricted stock grants.

Rhea-AI Summary

Bankwell Financial Group director-related entity buys small number of shares

An entity associated with director Lawrence B. Seidman, Seidman and Associates, L.L.C., made an open-market purchase of 170 shares of Bankwell Financial Group, Inc. common stock at $49.92 per share.

After this transaction, Seidman and Associates, L.L.C. held 217,884 shares of common stock indirectly. The filing also details multiple direct and indirect holdings for Seidman and several grants of restricted stock that vest over future dates, indicating ongoing equity-based compensation rather than a large new position change.

Rhea-AI Summary

Bankwell Financial Group director Lawrence B. Seidman reported additional indirect purchases of BWFG common stock. On May 13, 2026, affiliated investment entities completed several open‑market purchases totaling 1,930 common shares at prices around $50 per share, including buys by Chewy Gooey Cookies, L.P., Broad Park Investors, L.L.C., LSBK06-08, L.L.C., Seidman Investment Partnership II, L.P., Seidman Investment Partnership, L.P., and Seidman and Associates, L.L.C.

The filing also updates Seidman’s direct and indirect holdings, including shares held in a Deferred Compensation Plan, and details restricted stock awards granted between 2022 and 2026 under company stock plans, with scheduled vesting dates extending annually through February 7, 2029.

Rhea-AI Summary

Bankwell Financial Group EVP & Chief Credit Officer Christine Chivily reported an open‑market sale of 4,321 shares of Common Stock at $52.16 per share on May 1, 2026. After this transaction, she directly held 11,865 common shares.

The filing also shows multiple stock grants under the 2022 Bankwell Financial Group, Inc. Stock Plan, including restricted and performance restricted stock with vesting schedules extending to February 7, 2025, 2026, 2027, 2028 and 2029, depending on continued service and achievement of performance goals.

Rhea-AI Summary

Bankwell Financial Group director-related entities bought a total of 10,000 shares of Common Stock in open-market transactions on March 13, 2026. Purchase prices ranged from $46.95 to $46.99 per share, and all shares are held indirectly through investment partnerships and LLCs associated with Lawrence B. Seidman.

After these buys, example positions include Seidman and Associates, L.L.C. holding 216,904 shares and Broad Park Investors, L.L.C. holding 134,733 shares. Seidman also holds multiple restricted stock awards granted between 2022 and 2026 under company stock plans, with portions already vested and additional tranches scheduled to vest annually through 2029.

Rhea-AI Summary

Bankwell Financial Group, Inc. director Lawrence B. Seidman, through several affiliated investment entities, reported open‑market purchases of a total of 10,000 shares of Bankwell common stock on March 12, 2026 at prices around $46.87–$46.90 per share.

After these trades, the filing shows indirect holdings including 212,819 shares by Seidman and Associates, L.L.C., 175,667 shares by Seidman Investment Partnership II, L.P., and other entity positions. Seidman also holds multiple restricted stock awards that vest in annual tranches from 2026 through 2029 under Bankwell’s stock plans.

Rhea-AI Summary

Bankwell Financial Group director Lawrence B. Seidman, through several affiliated entities, reported open-market purchases totaling 10,000 shares of Bankwell common stock on March 11, 2026 at prices between $46.64 and $46.67 per share. The buying was executed by entities including Seidman and Associates, Seidman Investment Partnership entities, LSBK06-08, Broad Park Investors and Chewy Gooey Cookies.

The filing also updates Seidman’s equity-based compensation. It describes multiple restricted stock awards under Bankwell’s 2012 and 2022 stock plans, with portions already vested and additional tranches scheduled to vest annually from February 2026 through February 2029, reinforcing his ongoing equity exposure to the company.

Rhea-AI Summary

Bankwell Financial Group director Lawrence B. Seidman reported open-market purchases totaling 10,036 shares of Common Stock on March 10, 2026. Most of the buying was done through affiliated entities, including Seidman and Associates, L.L.C., Seidman Investment Partnership funds, LSBK06-08, L.L.C., Broad Park Investors, L.L.C., and Chewy Gooey Cookies, L.P., at prices around $46.93–$47.06 per share. A small portion, 36 shares, was bought directly in his own name. The filing also notes multiple restricted stock awards that will vest in stages between 2026 and 2029 under Bankwell’s stock plans.

Rhea-AI Summary

Bankwell Financial Group, Inc. director Jeffrey R. Dunne reported an indirect open-market purchase of 357 shares of common stock at $46.00 per share on March 6, 2026, through a Deferred Compensation Plan. Following this transaction, indirect holdings reported under the plan total 5,805 shares.

The filing also updates direct holdings and restricted stock awards. Footnotes describe 1,600 restricted shares granted on December 29, 2023, 1,800 granted on February 7, 2025, and 1,455 granted on February 9, 2026, each with scheduled vesting through February 2029.

Rhea-AI Summary

Bankwell Financial Group director Blake S. Drexler reported an open-market purchase of 27 shares of common stock at $46.00 per share on March 6, 2026. The transaction was made indirectly through a Deferred Compensation Plan, which now holds 36,854 shares for his benefit.

The filing also updates his other direct and indirect holdings, including 58,224 shares held by family members over which he exercises effective control and multiple restricted stock grants that vest in stages through 2029.

Rhea-AI Summary

Bankwell Financial Group director Carl M. Porto reported an open-market purchase of 393 shares of common stock at $46.00 per share on March 6, 2026, through a Deferred Compensation Plan, bringing that indirect holding to 21,700 shares.

The filing also lists several direct and indirect common stock holdings with updated share balances and details multiple restricted stock awards granted between 2022 and 2026. Footnotes describe vesting schedules for these awards, with portions already vested and additional tranches scheduled to vest annually through February 2029.

Rhea-AI Summary

Bankwell Financial Group, Inc. director Dale Eric J reported an open-market purchase of 612 shares of common stock at $46.00 per share on March 6, 2026 through a Deferred Compensation Plan, held as indirect ownership totaling 41,908 shares after the transaction.

The filing also lists multiple blocks of directly held common stock, with post-transaction holdings of 400, 534, 1,200, 1,455 and 37,330 shares. Footnotes describe several restricted stock grants under the 2022 stock plan, including awards where 1,200, 1,066 and 600 shares had vested as of the filing date.

Rhea-AI Summary

Bankwell Financial Group director Lawrence B. Seidman reported multiple indirect open-market purchases of Common Stock on March 6, 2026. Entities associated with him bought a total of 1,271 shares, including 370 shares at 46.00 and 320 shares at 45.61 per share.

The holdings are spread across a deferred compensation plan and several investment partnerships and LLCs. Separate footnotes describe prior restricted stock grants from 2022, 2023, 2025, and 2026, with portions vesting annually through 2029.

Rhea-AI Summary

Bankwell Financial Group director Lawrence B. Seidman reported new open‑market purchases of common stock made by several affiliated investment entities. On February 27, 2026, those entities bought a combined 2,520 shares of Bankwell common stock at prices between $46.77 and $46.90 per share, all reported as indirect ownership.

The filing also describes multiple restricted stock grants under Bankwell’s stock plans, including 1,455 shares granted on February 9, 2026 and earlier awards from 2025, 2023 and 2022, with portions scheduled to vest annually through February 7, 2029 and some tranches already vested as of the filing date.

Rhea-AI Summary

Bankwell Financial Group director Lawrence B. Seidman reported amended insider activity showing entities associated with him bought 10,000 shares of Bankwell common stock in open-market transactions on February 23, 2026 at prices around $47.39–$47.42, all held indirectly through investment partnerships and LLCs.

The amendment corrects an earlier filing that mistakenly used a sale code instead of a purchase code and also updates Seidman’s holdings to include several restricted stock grants, such as 1,455 shares granted on February 9, 2026 and prior grants of 1,800, 1,600, and another 1,600 shares with specified multi‑year vesting schedules.

Rhea-AI Summary

Bankwell Financial Group, Inc. director Lawrence B. Seidman filed an amended insider report updating his direct holdings of 534 shares of common stock. These shares relate to a grant of 1,600 restricted shares awarded on December 29, 2023 under the company’s 2022 stock plan.

According to the grant schedule, 533 shares vested on February 7, 2025, another 533 shares are scheduled to vest on February 7, 2026, and 534 shares are scheduled to vest on February 7, 2027. The footnote states that 1,066 shares had vested as of the filing date, so this amendment mainly documents vesting and current ownership rather than new open‑market buying or selling.

Rhea-AI Summary

Bankwell Financial Group director Lawrence B. Seidman reported indirect open‑market sales of a total of 10,000 shares of Bankwell Financial Group, Inc. common stock on February 23, 2026 through affiliated entities. The sales, at prices between $47.39 and $47.42 per share, were executed by Seidman and Associates, L.L.C., Seidman Investment Partnership, L.P., Seidman Investment Partnership II, L.P., LSBK06-08, L.L.C., Broad Park Investors, L.L.C., and Chewy Gooey Cookies, L.P. The filing also lists Seidman’s direct and deferred restricted stock holdings, including grants of 1,455, 1,800 and 1,600 shares scheduled to vest in annual installments through February 7, 2029.

Rhea-AI Summary

Bankwell Financial Group director Kevin D. Leitao reported an open-market sale of 200 shares of common stock at $46.39 per share. After this sale, he directly held 500 shares. Additional reported holdings include restricted stock awards totaling 1,455 and 1,800 shares with multi-year vesting, plus 4,500 shares held indirectly through an IRA.

Rhea-AI Summary

Bankwell Financial Group director Lawrence B. Seidman reported a series of indirect open-market purchases of Bankwell common stock on February 12, 2026 by entities he is associated with. These include buys such as 642 shares at $48.07 through Seidman and Associates, L.L.C. and 218 shares at $48.13 through Seidman Investment Partnership, L.P., along with smaller purchases by other affiliated LLCs and partnerships at prices around $48 per share.

Following these transactions, the filing lists significant indirect holdings in these entities, plus direct and deferred compensation holdings, including 4,151 shares held through a Deferred Compensation Plan and 17,346 shares held directly. The report also details multiple Bankwell restricted stock grants made between 2022 and 2026, with portions already vested and additional installments scheduled to vest annually through 2029 under the company’s stock plans.

Rhea-AI Summary

Bankwell Financial Group CEO Christopher R. Gruseke reported several equity transactions in company stock. On February 9, 2026, he acquired 7,654 shares under the 2022 stock plan, split between time-vested restricted stock and performance-based restricted stock that may vest between 2027 and 2029 if goals are met. He also received and vested an additional 1,516 performance shares tied to 2023 and 2024 results. To cover tax obligations on a total of 11,265 vesting shares, he sold 5,056 shares in an open-market transaction at about $49.79 per share through a company-sponsored cashless program.

Rhea-AI Summary

Bankwell Financial Group’s President and CBO Matt McNeill received new equity awards and sold shares to cover taxes. On February 9, 2026, he was granted 4,860 common shares at $0 under the 2022 stock plan. Half are time-based restricted stock, vesting in three annual installments starting February 7, 2027, and half are performance-based shares that may cliff vest on February 7, 2029 if goals are met.

He also received 1,143 shares that granted and vested the same day, tied to additional 2023–2024 performance shares. To cover tax liabilities on a total of 8,462 vested shares, 3,794 shares were sold through a company cashless program at about $49.83, leaving 45,019 directly held shares plus separate restricted and performance awards of 3,588 and 15,000 shares under the same 2022 plan.

Rhea-AI Summary

Bankwell Financial Group EVP & Chief Risk Officer Steven H. Brunner reported stock-based compensation and related share sales on February 9, 2026. He received 1,558 common shares at $0 under the 2022 Stock Plan, split between time-vested restricted stock and performance-based restricted stock with vesting dates in 2027 and 2029, if goals are met. He was also granted and vested an additional 518 shares tied to 2023–2025 performance awards.

To cover tax liabilities on the vesting of 3,717 shares, 1,876 shares were withheld and sold through the company-sponsored cashless stock exercise program at an average price of about $49.85, within a reported range of $49.52–$50.26. Following these transactions, Brunner continued to hold several blocks of Bankwell common stock directly.

Rhea-AI Summary

Bankwell Financial Group director Todd Lampert reported new stock awards. On February 9, 2026, he received 291 shares and 1,455 shares of restricted common stock at a price of $0 per share under the company’s stock plans, reflecting equity-based compensation grants.

The 291-share grant will fully vest on February 7, 2027. The 1,455-share grant will vest in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029. After these transactions, Lampert is shown as beneficially owning 15,866 shares directly, plus 8,608 shares in an IRA and 9,699 shares in his spouse’s IRA.

Rhea-AI Summary

Bankwell Financial Group director Eric J. Dale received a grant of 1,455 shares of restricted common stock on February 9, 2026. The award was issued at a price of $0 per share under the 2022 Bankwell Financial Group, Inc. Stock Plan.

The restricted stock vests in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029. The Form 4 also lists Dale’s other holdings, including directly held common stock and 41,296 shares held indirectly through a Deferred Compensation Plan, along with prior restricted stock grants with multi‑year vesting schedules.

Rhea-AI Summary

Bankwell Financial Group director Darryl Demos received a grant of 1,455 shares of restricted common stock on February 9, 2026. The award was granted at a price of $0 per share under the 2022 Stock Plan and is scheduled to vest in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029.

The Form 4 also shows Demos’ previously granted restricted stock awards, including 1,600 shares granted on December 30, 2022, 1,600 shares granted on December 29, 2023, and 1,800 shares granted on February 7, 2025, with portions of each already vested according to their multi-year schedules.

Rhea-AI Summary

Bankwell Financial Group director Blake S. Drexler received a grant of 1,455 shares of restricted common stock on February 9, 2026 at $0 per share. These shares were issued under the 2022 Stock Plan and are scheduled to vest in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029.

In addition to this new award, he reports various existing direct and indirect holdings, including shares in an IRA/401(k), a deferred compensation plan, and 58,224 shares held by family members over which he exercises effective control. He also reports 160,861 directly held common shares.

Rhea-AI Summary

Bankwell Financial Group director Jeffrey R. Dunne received an equity grant of 1,455 shares of common stock on February 9, 2026. The shares are restricted stock issued under the 2022 Bankwell Financial Group, Inc. Stock Plan at a stated price of $0 per share.

The grant vests in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029, aligning compensation with longer-term service. Following the transaction, he directly holds 1,455 restricted shares, along with other direct and indirect common stock holdings reported in the filing.

Rhea-AI Summary

Bankwell Financial Group director Anahaita N. Kotval received a new equity award. On February 9, 2026, she was granted 1,455 shares of Bankwell common stock as restricted stock under the 2022 Stock Plan at a price of $0 per share.

The grant vests in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029. The filing also notes prior restricted stock grants from December 29, 2023 and February 7, 2025, and that 2,500 of her 6,666 directly held shares are owned jointly with her spouse.

Rhea-AI Summary

Bankwell Financial Group director granted restricted stock

Bankwell Financial Group director Kevin D. Leitao received a grant of 1,455 shares of common stock on February 9, 2026 under the company’s 2022 stock plan. The award vests in three equal installments of 485 shares on February 7, 2027, 2028, and 2029.

A prior restricted stock grant of 1,800 shares from February 7, 2025 is also outstanding, with 600 shares vested on February 7, 2026 and another 600 shares scheduled to vest on February 7, 2027 and 2028, respectively.

Rhea-AI Summary

Bankwell Financial Group director Carl M. Porto reported an equity award of common stock. On February 9, 2026, he received 1,455 shares of restricted stock at $0 per share under the 2022 Stock Plan. These shares are scheduled to vest in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029.

After this grant, Porto directly holds several blocks of common stock, including 1,455 newly granted restricted shares and other vested holdings, as well as indirect holdings through a law firm pension plan and a deferred compensation plan. No derivative securities are reported.

Rhea-AI Summary

Bankwell Financial Group director Lawrence B. Seidman received a new equity grant in the company. On February 9, 2026, he was awarded 1,455 shares of Bankwell common stock as restricted stock at a price of $0 under the 2022 Stock Plan.

The grant vests in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029, aligning his compensation with longer-term performance. The filing also lists his existing direct holdings and substantial indirect ownership through several investment entities and plans.

Rhea-AI Summary

Bankwell Financial Group, Inc. reported an equity grant to Chief Innovation Officer Ryan Jason Hildebrand. On February 9, 2026, he was awarded 3,116 shares of common stock at $0 under the 2022 Stock Plan.

Of this grant, 1,558 shares are time-based restricted stock vesting in three equal annual installments starting on February 7, 2027. The remaining 1,558 shares are performance restricted stock that vest on February 7, 2029 if the performance goal is achieved. Following the reported transaction, he directly beneficially owns 3,116 shares from this grant, 3,334 other common shares, and 15,000 performance restricted shares from earlier awards, all under the same 2022 Stock Plan.

Rhea-AI Summary

Bankwell Financial Group EVP & CFO Courtney E. Sacchetti reported equity compensation and a related share sale in common stock of Bankwell Financial Group, Inc.

On February 9, 2026, Sacchetti received 1,994 common shares at $0 under the 2022 Stock Plan. According to the footnotes, 997 of these are time-based restricted stock vesting in three annual installments starting February 7, 2027, and 997 are performance restricted stock with a three-year cliff vesting on February 7, 2029 if performance goals are achieved.

Also on February 9, 2026, Sacchetti was granted and vested an additional 245 shares tied to 2024 and 2025 performance. To cover tax liabilities for vesting a total of 2,220 shares, 1,062 shares were withheld and sold through a company-sponsored cashless stock exercise program at a reported price of $49.79 per share, within a range of $49.47–$50.21. Following these transactions, Sacchetti reported direct ownership positions across several restricted and performance-based stock grants with varying vesting schedules.

Rhea-AI Summary

Bankwell Financial Group EVP & Chief Credit Officer Christine Chivily reported multiple stock transactions on February 9, 2026. She received 2,054 shares under the 2022 stock plan, split between time-based restricted stock vesting from February 7, 2027 and performance shares that may cliff vest on February 7, 2029 if goals are met.

She also received and immediately vested 581 performance-related shares tied to 2023–2025 awards. To cover tax liabilities on a total of 4,232 vested shares, 1,985 shares were withheld and sold through a company cashless program at prices ranging from $49.38 to $50.15, leaving her with 16,186 directly held common shares plus previously granted restricted and performance awards.

Rhea-AI Summary

Bankwell Financial Group, Inc. principal accounting officer Angelo G. Fusaro reported stock compensation and a related tax sale. On February 9, 2026, he received 414 shares of common stock at $0 under the 2022 Stock Plan, vesting in three equal annual installments starting on February 7, 2027.

On the same date, 316 shares were sold at $49.88 through a company cashless program to cover taxes on the vesting of 852 shares. Following these transactions, he directly owned 2,273 common shares, and the filing outlines several prior restricted stock grants under the 2022 plan with staggered vesting through future years.